PROSPECT CLOSTRIDIUM DIFFICILE TOXIN A/B MICROPLATE ASSAY— 510(k) K033479

Name: FDA 510(k) clearance K033479
Creator: U.S. Food and Drug Administration
Published: 2004-02-26

Substantially Equivalent

Remel, Inc.

FDA 510(k) clearance K033479 for PROSPECT CLOSTRIDIUM DIFFICILE TOXIN A/B MICROPLATE ASSAY, Substantially Equivalent on 2004-02-26. Applicant: Remel, Inc.. Device class: 1.

Clearance details

Applicant: Remel, Inc.
Product code: Code LLH
Device class: Class 1
Regulation: 21 CFR 866.2660
Advisory panel: Microbiology
Date received: 2003-11-03
Decision date: 2004-02-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ramsey, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLH

view all

K193490 — SensiTox C. difficile Toxin Test2021-07-08
K102242 — OSOM C. DIFFICILE TOXIN A/B TEST2010-12-21
K091109 — XPERT C. DIFFICILE2009-07-09
K090239 — PROGASTRO CD ASSAY2009-04-16
K082499 — C. DIFF QUIK CHEK COMPLETE2009-03-26

More clearances from Remel, Inc.

view all

K162620 — Remel Spectra ESBL2017-05-01
K131804 — REMEL XPECT FLU A&B2013-07-12
K092407 — REMEL SPECTRA MRSA2010-10-08
K072827 — RPMI 1640 AGAR W/MOPS AND 2% GLUCOSE2007-11-26
K041951 — XPECT CLOSTRIDIUM DIFFICILE TOXIN A/B2004-11-15

Data sourced from openFDA. This site is unofficial and independent of the FDA.